These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6283345)

  • 41. Expression of type III hyperlipoproteinemia in an adolescent patient with hypothyroidism.
    Lindner MA; Illingworth DR
    J Pediatr; 1988 Jul; 113(1 Pt 1):86-9. PubMed ID: 3385535
    [No Abstract]   [Full Text] [Related]  

  • 42. A modified thymol turbidity test in hyperglobulinaemia.
    Maclagan NF; Pradhan K; Sule U; Wallsgrove R; Cooke KB; Lee J
    Clin Chim Acta; 1974 Jun; 53(3):339-49. PubMed ID: 4367868
    [No Abstract]   [Full Text] [Related]  

  • 43. A comparison of the Sf 0 to 1000 plasma lipoproteins from rabbits fed cholesteroil and humans with type III hyperlipoproteinaemia.
    Bosanquet AG; Munster D; Bickerstaffe R; Fraser R
    Int J Biochem; 1980; 12(3):473-7. PubMed ID: 7418942
    [No Abstract]   [Full Text] [Related]  

  • 44. Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E.
    Gregg RE; Zech LA; Schaefer EJ; Brewer HB
    Science; 1981 Feb; 211(4482):584-6. PubMed ID: 7455696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Type III hyperlipoproteinemia in a patient with idiopathic hemochromatosis.
    Feussner G; Ziegler R
    Hum Genet; 1991 Jan; 86(3):326-8. PubMed ID: 1997392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cysteamine in treatment of type III hyperlipidaemia?
    Fisher EA; Gahl WA
    Lancet; 1982 Nov; 2(8308):1131-2. PubMed ID: 6128453
    [No Abstract]   [Full Text] [Related]  

  • 47. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site.
    Weisgraber KH; Innerarity TL; Mahley RW
    J Biol Chem; 1982 Mar; 257(5):2518-21. PubMed ID: 6277903
    [No Abstract]   [Full Text] [Related]  

  • 48. Determination of human low density lipoprotein apoproteins (apo-ldl) by the Lowry procedure: standardisation and effect of sodium chloride.
    van der Bijl P; van Gent CM
    Clin Chim Acta; 1975 Jun; 61(3):407-9. PubMed ID: 168009
    [No Abstract]   [Full Text] [Related]  

  • 49. [Trends in the study of genetic engineering in cardiovascular diseases].
    Kita T
    Nihon Rinsho; 1986 May; 44(5):1239-53. PubMed ID: 3018327
    [No Abstract]   [Full Text] [Related]  

  • 50. [Hyperlipoproteinemia type III. Diagnostic possibilities and clinical picture].
    Kusić M; Gavrilović M
    Vojnosanit Pregl; 1983; 40(2):88-91. PubMed ID: 6880108
    [No Abstract]   [Full Text] [Related]  

  • 51. Falsely low direct HDL-cholesterol results in a patient with dysbetalipoproteinemia.
    Roberts WL; Leary ET; Lambert TL; Moulton L; Goestch JL
    Clin Chem; 2000 Apr; 46(4):560-2. PubMed ID: 10760233
    [No Abstract]   [Full Text] [Related]  

  • 52. [Familial type III hyperlipoproteinemia].
    Igarashi M
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():333-9. PubMed ID: 17824053
    [No Abstract]   [Full Text] [Related]  

  • 53. Follow-up of type III hyperlipoproteinaemia in a child.
    Fung M; Bebb R; Frohlich J
    Lancet; 2001 Dec 22-29; 358(9299):2171. PubMed ID: 11784667
    [No Abstract]   [Full Text] [Related]  

  • 54. [Primary hyperlipoproteinemias].
    Muñoz TB; Gil MC
    Rev Chil Pediatr; 1981; 52(6):502-6. PubMed ID: 7347863
    [No Abstract]   [Full Text] [Related]  

  • 55. Type III hyperlipoproteinemia.
    Hakim J; Khan AR; Jian A
    Clin Cardiol; 2002 Apr; 25(4):193. PubMed ID: 12000078
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical features of type III hyperlipoproteinemia: analysis of 64 patients.
    Feussner G; Wagner A; Kohl B; Ziegler R
    Clin Investig; 1993 May; 71(5):362-6. PubMed ID: 8508005
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma cholesterol concentration and extra lipid band in monoclonal gammopathies.
    Levy Y; Aviram M; Spira G; Tatarsky I; Brook GJ; Carter A
    Postgrad Med J; 1984 Jul; 60(705):449-53. PubMed ID: 6431399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune complex hyperlipidemia induced by an apolipoprotein-reactive immunoglobulin A paraprotein from a patient with multiple myeloma. Characterization of this immunoglobulin.
    Kilgore LL; Patterson BW; Parenti DM; Fisher WR
    J Clin Invest; 1985 Jul; 76(1):225-32. PubMed ID: 3160725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cutaneous xanthoma in association with paraproteinemia in the absence of hyperlipidemia.
    Feingold KR; Castro GR; Ishikawa Y; Fielding PE; Fielding CJ
    J Clin Invest; 1989 Mar; 83(3):796-802. PubMed ID: 2921322
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atypical type III hyperlipoproteinemia in a patient with Ig A myelomatosis.
    Feussner G; von Hodenberg E; Ziegler R
    Klin Wochenschr; 1990 May; 68(10):526-32. PubMed ID: 2374370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.